JRSIS Health Care Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 0.013567 million. Net loss was USD 0.119133 million compared to USD 0.13246 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.023 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.023 a year ago. Basic loss per share was USD 0.02 compared to USD 0.023 a year ago. Diluted loss per share was USD 0.02 compared to USD 0.023 a year ago.
For the nine months, revenue was USD 0.056884 million. Net loss was USD 0.343302 million compared to USD 33.68 million a year ago. Basic loss per share from continuing operations was USD 0.059 compared to USD 0.07 a year ago. Diluted loss per share from continuing operations was USD 0.059 compared to USD 0.07 a year ago. Basic loss per share was USD 0.059 compared to USD 8.298 a year ago. Diluted loss per share was USD 0.059 compared to USD 8.298 a year ago.